DiagnoCure restructures into 2 segments
February 15, 2010 by leonardzehr · Leave a Comment
DiagnoCure (TSX: CUR) has announced a reorganization into two business segments — an administrative headquarters in Quebec City to hold its patents and DiagnoCure Oncology Laboratories, its U.S. sales, marketing and service laboratory operations. As part of the realignment, CEO John Schafer will relocate to the U.S. to lead the commercialization of the Previstage GCC [...]
Listen to BioTuesdays 
